1. MARKETS
  2. SECTOR : CHEMICALS & PETROCHEMICALS
  3. INDUSTRY : MAJOR DIVERSIFIED CHEMICALS
  4. INGEVITY CORP
69.76-1.65(-2.31%)
224.0K
XNYS Volume

XNYS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Ingevity Corp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Ingevity Corp share price target, revenues, EPS, net income and more

Ingevity Corp quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEGATIVE

    Quarterly Revenue Ingevity Corp Jun-2026 Quarterly Revenue is $314 Million which is growth of -14.0% YoY.

  • POSITIVE

    Quarterly Net Profit Ingevity Corp Jun-2026 Quarterly Net Profit is $35 Million which is growth of 124.1% YoY.

Ingevity Corp, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
314.1258255.1333.1365.1284298.8376.9390.6340.1371.7446481.8
Cost Of Rev.
175.1141.6167.3199.2227.2170.6196.9247267.4240.4312.2317328.8
Gross Profit
139116.487.8133.9137.9113.4101.9129.9123.299.759.5129153
⌄
45.147.44951.15250.846.745.448.75450.647.859.7
Operating Profit
93.96938.882.885.962.655.284.574.545.78.981.293.3
-14.1-15.8-16.8-18.6-18.9-19.6-21.2-24.2-23.2-22.3-22.7-23.1-21.6
Profit Before Tax
50.730.2-105.462.2-142.726.88.8-137.9-334.6-71.9-15432.147.7
Tax
10.96.8-26.621.43.86.3-7.8-30.7-50.9-15.9-37.26.912.2
⌄
35.359.8-84.643.5-146.520.516.6-107.2-283.7-56-116.825.235.5
Diluted NI Avail to Com Stockholders Ann.
35.359.8-84.643.5-146.520.516.6-107.2-283.7-56-116.825.235.5
Basic EPS
11.7-2.41.2-40.60.5-3-7.8-1.5-3.20.71
Diluted EPS After ExtraOrdinary
1.71.10.21.10.40.80.81.21.10.4-1.21.31.5
Number Of Shares End
34.735.335.736.336.536.436.436.336.336.336.236.236.4
Net Income Continuing Discontinued Operations
35.359.8-84.643.5-146.520.516.6-107.2-283.7-56-116.825.235.5
Normalized Income
61.541.421.348.351.136.434.745.436.819.17.844.251.6
Interest Income
1.21.21.111.11.24.30.70.913.40.71.2
Interest
15.31716.719.62020.825.524.924.123.326.123.822.8
Net Interest Income
-14.1-15.8-16.8-18.6-18.9-19.6-21.2-24.2-23.2-22.3-22.7-23.1-21.6
EBIT
64.846-89.880.8-123.846.430-113.7-311.4-49.6-131.355.269.3
EBITDA
86.868.7-61.9108.8-98.271.355.2-46.8-284.1-20-106.290.4100.7
Reconciled Cost Of Rev.
175.1141.6167.3199.2227.2170.6196.9247267.4240.4312.2317328.8
Reconciled Depr.
2222.727.92825.624.925.226.227.329.625.135.231.4
Profit From Continuing Operations
35.359.8-84.643.5-146.520.516.6-107.2-283.7-56-116.825.235.5
Normalized EBITDA
113.789.551.8110.8108.283.274.6106.299.971.5-5.5117.5125.3
*All financials are in USD Million and price data in USD

Ingevity Corp competitor comparison and performance snapshot within industry

Ingevity Corp annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEGATIVE

    Annual Revenue Ingevity Corp Dec-2025 Annual Revenue is $1,168 Million which is growth of -17.0% YoY.

  • POSITIVE

    Annual Net Profit Ingevity Corp Dec-2025 Annual Net Profit is $-167 Million which is growth of 61.2% YoY.

Ingevity Corp, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-11.2%
-0.8%
 1,167.61,406.41,692.11,668.31,391.51,216.11,292.91,133.6972.4908.3968
Cost Of Rev. Ann.
-13.7%
-1.2%
683.2706.1951.71,220.21,098.2878.7750.6810.9716.8643.4633.9687
Gross Profit Ann.
-6.8%
-0.2%
477.1461.5454.7471.9570.1512.8465.5482416.8329274.4281
Operating Exp. Ann.
-4.5%
3%
192.6199.6194.8215.5229.1205.6172182.8153.9126.2114114
Operating Profit Ann.
-8.4%
-2.3%
284.5261.9259.9256.4341307.2293.5299.2262.9202.8160.4167
-
-
-65.3-73.9-90.9-87-54.3-47.7-42.2-46.9-29.8-15.8-17.9-21
Other Exp. Ann.
-
-
 -330.1-704.6-179.5-17.1-96.7-16.2-24.4-11.3-12.2-55.5-8
PBT Ann.
-
-
37.7-142.1-535.6-10.1269.6162.8235.1227.9221.8174.887138
Tax Ann.
-47.9%
-31.3%
12.58.2-105.3-4.75844.753.744.24029.642.653
⌄
-
-
54-167.1-430.3-5.4211.6118.1181.4183.7169.1126.535.280
Diluted NI Avail to Com Stockholders Ann.
-
-
54-167.1-430.3-5.4211.6118.1181.4183.7169.1126.535.280
EPS Ann.
-
-
 -4.6-11.9-0.25.534.44.4430.82.1
Diluted EPS Ann.
-
-
 -4.6-11.9-0.25.534.44.4430.82.1
Number Of Shares End
-1.5%
-2.8%
 35.736.436.237.439.341.141.841.942.142.142.1
Total Exp. Ann.
-12%
-0.4%
 905.71,146.51,435.71,327.31,084.3922.6993.7870.7769.6747.9801
Net Income Continuing Discontinued Operations Ann.
-
-
54-167.1-430.3-5.4211.6118.1181.4183.7169.1126.535.280
Normalized Income Ann.
-13.2%
-5.6%
172.5151.5128.3144.7231.4209.5202.6208.1176.1109.98898
Interest Income Ann.
-16.3%
-2.1%
4.54.46.96.37.54.44.97.73.42.31.4-
Interest Ann.
7.7%
10.4%
68.677.197.893.361.852.147.154.633.218.119.321
EBITDA Ann.
-55.9%
-37.2%
202.437-318.8200.3432.7320.4377.5359.8308.6231143.7194
Reconciled Cost Of Rev. Ann.
-13.7%
-1.2%
683.2706.1951.71,220.21,098.2878.7750.6810.9716.8643.4633.9687
Reconciled Depr. Ann.
-0.7%
1.2%
100.6106.4108.3122.8108.8109.9100.2855740.438.835
Profit From Continuing Operations Ann.
-
-
54-167.1-430.3-5.4211.6118.1181.4183.7181.8145.244.485
Normalized EBITDA Ann.
-8.2%
-2.8%
365.8345.9355.8360.9447.5429.1398.3395.7324.3243.8199.5212
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
-17%
2Y CAGR
-16.9%
3Y CAGR
-11.2%
5Y CAGR
-0.8%
7Y CAGR
0.4%
10Y CAGR
1.9%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
2.5%
2Y CAGR
-3.8%
3Y CAGR
-4.5%
5Y CAGR
3%
7Y CAGR
3.8%
10Y CAGR
5.8%
Operating Expenses Annual Cr growth is stable compared to historical averages.

Ingevity Corp balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Ingevity Corp Dec-2025 Total Shareholders Fund is $30 Million which is growth of -84.8% YoY.

  • NEGATIVE

    Total Assets Ingevity Corp Dec-2025 Total Assets is $1,651 Million which is growth of -18.4% YoY.

Ingevity Corp, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-15.5%
-6.7%
1,651.12,022.62,623.32,736.52,4692,334.52,141.71,315.2929.6832.8782
⌄
-7.3%
-0.9%
1,621.41,827.41,991.92,038.21,795.21,692.41,610.9976.5651.7698.2260
⌄
-65.1%
-45.9%
29.7195.2631.4698.3673.8642.1530.8338.7263.9127517
Total Capitalization Ann.
-18.1%
-9%
1,191.11,534.92,014.22,170.81,923.81,909.51,759.21,079.9707.9608.3517
Tangible Assets Ann.
-
-
-190.1-303.9-281.4-276-146.9-200.5-324.367.3228.196.5484
Working Capital Ann.
-33%
-22.6%
112.9229.1295.7375.5456405.3247.7239.4215.5158.3202
Invested Capital Ann.
-17.1%
-8.5%
1,238.21,596.22,098.62,171.71,943.41,935.51,781.71,091.1717.3615.8526
Tangible Book Value Ann.
-
-
-190.1-303.9-281.4-276-146.9-200.5-324.367.3228.196.5484
Borrowings Ann.
-6.7%
-1.6%
1,242.71,454.71,534.51,530.71,323.21,344.31,304.7752.4453.4488.889
Net Debt Ann.
-6.8%
1.8%
1,130.41,3331,371.31,396.7994.21,035.71,194.4674.9365.5458.3-
Share Issued Ann.
0.5%
0.5%
43.943.643.543.243.142.942.742.342.242.142
Number Of Shares End
-1.5%
-2.8%
35.736.436.237.439.341.141.841.942.142.142.1
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
-18.4%
2Y CAGR
-20.7%
3Y CAGR
-15.5%
5Y CAGR
-6.7%
7Y CAGR
3.3%
10Y CAGR
7.8%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
29.2%
2Y CAGR
-3%
3Y CAGR
4%
5Y CAGR
8.8%
7Y CAGR
9.3%
10Y CAGR
13.4%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-84.8%
2Y CAGR
-78.3%
3Y CAGR
-65.1%
5Y CAGR
-45.9%
7Y CAGR
-29.4%
10Y CAGR
-24.9%
Total ShareHolders Funds Annual is falling faster than historical averages.

Ingevity Corp ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Ingevity Corp Book Value Per Share is $4 which is growth of -27.5% YoY.

  • NEUTRAL

    ROE Ingevity Corp ROE is 0% which is growth of 0% YoY.

Ingevity Corp, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--18.52%-0.20%8.13%4.92%8.11%10.63%15.07%14.36%4.36%10.67%
ROE Ann. %
-
-
--104.11%-0.81%30.84%17.95%30.93%42.25%56.12%64.72%10.93%17.13%
ROIC %
-
-
-2-4.51.41.92.83.24.96.72.31.5
OPM Ann. %
3.1%
-1.5%
22.43%18.48%15.15%20.44%22.08%24.13%23.14%23.19%20.86%17.66%17.25%
Inventory Turnover Ratio Ann.
-
-
-3.63.83.84.13.744.14.14.24.9
Asset Turnover Ann. %
-
-
-0.60.60.60.60.50.811.11.11.3
Working Capital Turnover Ann.
32.8%
28%
10.36.15.74.43.135.24.74.55.74.8
Quick Ratio Ann.
-
-
-0.90.91.11.71.91.11.21.311.4
Current Ratio Ann.
-
-
-1.91.82.22.72.82.22.32.42.23.1
Interest Coverage Ratio Ann.
-
-
--4.50.95.44.165.27.710.75.57.6
LT Debt To Equity Ann.
-
-
-7.12.32.21.922.42.21.73.80.2
*All financials are in USD Million and price data in USD

Ingevity Corp cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity Ingevity Corp Dec-2025 Cash From Operating Activity is $331 Million which is growth of 157.5% YoY.

  • POSITIVE

    Net Cash Flow Ingevity Corp Dec-2025 Net Cash Flow is $22 Million which is growth of 201.9% YoY.

Ingevity Corp, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
1.9%
-1.2%
331.2128.6205.1313.1293352.4275.7252174.3127.973
-
-
-57.5-79.5-77.3-553.9-140.6-110.6-658.3-414.4-58.6-126.4-90
-
-
-252.2-70.2-99.948.1-133.1-50.2369.2153.7-57.8-3.427
Cash Plus Cash Eqv. End Of Year Ann.
13.4%
-15.3%
112.686.6111.977.3276258.464.677.887.930.532
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-35.4%
21.5-21.127.9-192.719.3191.6-13.4-8.757.9-1.910
Cash Plus Cash Eqv. Begin Of Year Ann.
-32%
6%
86.6111.984.3276258.464.677.887.930.53220
Income Tax Paid Supplemental Data Ann.
-45.9%
-28.5%
8.726.9-54.853.746.614.934.861.922.4-
Interest Paid Supplemental Data Ann.
8.7%
12.2%
70.485.4-54.847.539.648261615.17
Capex Ann.
-
-
-57.7-77.6-109.8-142.5-103.8-105.9-114.8-93.9-52.6-56.7-102
Issuance Of Capital Stock Ann.
-
-
-----------
Issuance Of Debt Ann.
-37%
-20.5%
291.3404.5376.31,164.7919.21,174.8303.975411.96
Repayment Of Debt Ann.
-
-
-483.6-470.6-382.9-964.8-25.3-866.4-788.9-111.9-9.4-6
Repurchase Of Capital Stock Ann.
-
-
-56.3-92.1-145.2-109.4-88-6.4-47.4-6.6--
Free Cash Flow Ann.
17%
2.1%
273.55195.3170.6189.2246.5160.9158.1121.771.2-29
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
157.5%
2Y CAGR
27.1%
3Y CAGR
1.9%
5Y CAGR
-1.2%
7Y CAGR
4%
10Y CAGR
16.3%
Cash from Operating Activity Annual growth is higher than historical averages.